Entia Biosciences Inc

Over The Counter Market:ERGOUnited States

Entia Biosciences, Inc. develops pharmaceutical-grade organic compounds, including a foundational compound called ErgoD2. The Company also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The Company's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The Company's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.

Contact Information

Headquarters

13565 SW TUALATIN-SHERWOOD RD. SUITE 800SHERWOOD, OR, United States 97140

Phone

509-427-5132

Fax

503-610-1876

Executives

Chairman of the Board, Acting Chief Financial Officer, Chief Scientific and Technology Officer

Marvin Hausman

President, Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Executive Vice President

Timothy Timmins

Secretary, Director

Elliot Shelton